Clinical trial
SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada
NCT00323687 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00323687 |
|---|---|
| Title | SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada |
| Official title | Switch to a Completely ONce Daily Regimen Containing Emtricitabine/Tenofovir - Fixed Dose Combination Plus Third QD Partner: "SONETT" |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV-1 Infection |
| Intervention type | Drug |
| Interventions | Truvada |
| Enrollment | 50 |
| Start date | Sep 1, 2004 |
| Primary completion | Oct 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | May 9, 2006 |
| Last update posted | Jun 9, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: